Company CVAbout Tyche Industries Ltd 
Tyche Industries Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Tyche Industries Limited (formerly known as Siris Soft Limited) was incorporated on Jul' 23, 1998. TIL is one of the largest manufacturers in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe. Company's operations are predominantly related to the manufacture of bulk drugs intermediates. The company has established two advanced development centers in the area of e-commerce in New Jersey, USA and Hyderabad.
Company Coordinates
Company Details
H No C-21/A Road No 9, Film Nagar Jubilee Hills Hyderabad Telangana : 500096
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Silver Oak Technologies Private Limited (19.31%)
Highest Public shareholder
Plutus Techlabs Private Limited (6.4%)
Individual Investors Holdings
26.67%
Board of Directors
Management
Designation
Remuneration
G Ganesh Kumar
Chairman & Managing Director
1.05 cr
Boosa Eswar
Independent Director
2.0 lacs
P Vijaya Lakshmi
Director
2.0 lacs
Panchakarla Sai Sudhakar
Independent Director
1.88 lacs
G Sandeep Kumar
Executive Director
1.05 cr
Venkataraju Gupta Kollepalli
Non Executive Director
2.0 lacs
Satya Ranjan Jena
Company Sec. & Compli. Officer
8.11 lacs
Srinivas Gelli
Non Executive Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Recemic Setraline
12.08
23.00%
RHQ
10.34
19.68%
TMH
8.05
15.32%
Recemic Setraline
Recemic Setraline
RHQ
RHQ
TMH
TMH
Stock DNARevenue and Profits:
Net Sales:
14 Cr
(Quarterly Results - Sep 2025)
Net Profit:
2 Cr
Pharmaceuticals & Biotechnology
INR 119 Cr (Micro Cap)
12.00
40
2.60%
-0.19
6.85%
0.84
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
